| 常用名 | 达巴万星盐酸盐 | CAS号 | 2227366-51-8 |
|---|---|---|---|
| 价格 | ¥4500.0/1g | 纯度 | 98.0% |
| 备货期 | 1天 | 库存 | 现货 |
| 产品详情(用途,包装等)
中文名 盐酸道古霉素 英文名 Dalbavancin hydrochloride 别名 盐酸道古霉素 道古霉素盐酸盐 达巴万星盐酸盐 英文别名 Dalbavancin hydrochloride CAS 2227366-51-8 化学式 C88H101Cl3N10O28 分子量 1853.15 存储条件 under inert gas (nitrogen or Argon) at 2-8°C 物化性质 生物活性 Dalbavancin hydrochloride(MDL-63397 hydrochloride) 是一种半合成的脂糖肽抗生素,对革兰氏阳性细菌具有有效的杀菌活性。Dalbavancin hydrochloride 抑制金黄色葡萄球菌和炭疽芽孢杆菌的 MIC90 分别为 0.06 μg/mL 和 0.25 μg/mL。2227366-51-8 - 用途与合成方法 开放数据 待核验数据 体外研究 Dalbavancin is a parenterally administered semisynthetic lipoglycopeptide developed to combat infections caused by resistant gram-positive pathogens. Dalbavancin exhibits potent in vitro bactericidal activity against gram-positive pathogens including S. aureus (MRSA), VISA, and non-VanA strains of VRE. Dalbavancin is developed for the treatment of complicated skin and skin structure infections (cSSSIs), predominantly those caused by MRSA and β-hemolytic streptococci , organisms against which it has shown greater potency than existing glycopeptide therapeutic agents. 体内研究 Dalbavancin (15-240 mg/kg; intraperitoneal injection; every 36 h or 72 h; for 14 days; female BALB/c mice) treatment has a survival rate of 80% to 100% of mice with all dose regimens. Animal Model: Female BALB/c mice (6-8 weeks) challenged with Ames strain of B. anthracis Dosage: 15 mg/kg, 30 mg/kg, 60 mg/kg, 120 mg/kg, 240 mg/kg Administration: Intraperitoneal injection; every 36 h or 72 h; for 14 days Result: The efficacy was 80 to 100%, as determined by the rate of survival at 42 days, when treatment was initiated 24 h postchallenge with regimens of 15 to 120 mg/kg every 36 h or 30 to 240 mg/kg every 72 h. 更多
|